ICD-10-CM Billable Code

F15.2

Other stimulant dependence

Clinical Classification Guidelines

Excludes Type 1

  • other stimulant abuse (F15.1-)
  • other stimulant use, unspecified (F15.9-)

Medical Intelligence & Overview

ICD-10 code F15.2 refers to a condition characterized by dependence on stimulants that are not specifically classified elsewhere. Stimulants are substances that increase alertness, attention, and energy. Dependence on these substances can significantly impact an individual's health, behavior, and daily functioning. This article aims to provide an overview of stimulant dependence, its causes, symptoms, how it is diagnosed, and available treatment options.

Causes & Symptoms

Clinical Causes: Repeated use of stimulant substances such as amphetamines, methamphetamines, or other prescription stimulants over time. Psychological factors, including stress, trauma, or mental health disorders, that lead to substance use as a coping mechanism. Social influences, such as peer pressure or environments where stimulant use is common. Biological predispositions, including genetic factors that increase susceptibility to dependence. Misuse of prescription medications intended for attention deficit hyperactivity disorder (ADHD) or narcolepsy.

Key Symptoms: Strong cravings or compulsive desire to consume stimulants. Increasing tolerance, requiring larger doses for the same effect. Withdrawal symptoms when not using the substance, such as fatigue, depression, or irritability. Restlessness or agitation. Impaired judgment and decision-making abilities. Difficulty concentrating or maintaining focus. Elevated heart rate, increased blood pressure, or other cardiovascular issues. Sleep disturbances, including insomnia or hypersomnia. Signs of emotional instability, such as anxiety or paranoia.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of stimulant dependence involves a comprehensive clinical interview conducted by a healthcare professional, assessment of the patient's history of substance use, and observation of signs and symptoms indicative of dependence. Diagnostic criteria often align with standardized frameworks such as the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), which evaluates aspects like tolerance, withdrawal, unsuccessful efforts to cut down, and continued use despite adverse consequences. Laboratory tests or screenings may be utilized to confirm recent stimulant use or exclude other health issues.

Treatment Protocols: Treatment approaches for stimulant dependence are tailored to individual needs and may include the following components: - **Detoxification:** Medical supervision during withdrawal to manage symptoms safely. - **Behavioral therapies:** Cognitive-behavioral therapy (CBT), contingency management, and motivational interviewing can help modify problematic patterns of use and develop coping skills. - **Support groups:** Participation in peer support programs such as Narcotics Anonymous may provide ongoing encouragement. - **Medication-assisted treatment:** While no specific medications are approved solely for stimulant dependence, some drugs are studied or used off-label to address cravings or co-occurring mental health conditions. - **Addressing co-occurring disorders:** Managing mental health issues like depression or anxiety that often accompany dependence. Long-term recovery depends on a comprehensive, multidisciplinary approach and ongoing support to prevent relapse.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F15.2 a billable ICD-10 code?
Yes, F15.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F15.2?
Clinical documentation must specify the nature of Other stimulant dependence and any associated comorbidities for accurate reporting.

Cite this Clinical Reference